KR101736478B1 - Method for manufacturing lotions with effective in treating acne - Google Patents
Method for manufacturing lotions with effective in treating acne Download PDFInfo
- Publication number
- KR101736478B1 KR101736478B1 KR1020170003650A KR20170003650A KR101736478B1 KR 101736478 B1 KR101736478 B1 KR 101736478B1 KR 1020170003650 A KR1020170003650 A KR 1020170003650A KR 20170003650 A KR20170003650 A KR 20170003650A KR 101736478 B1 KR101736478 B1 KR 101736478B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- skin
- lotion
- solvent
- mixing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006210 lotion Substances 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims abstract description 11
- 208000002874 Acne Vulgaris Diseases 0.000 title abstract description 29
- 206010000496 acne Diseases 0.000 title abstract description 29
- 238000004519 manufacturing process Methods 0.000 title abstract description 13
- 239000004251 Ammonium lactate Substances 0.000 claims abstract description 10
- 229940059265 ammonium lactate Drugs 0.000 claims abstract description 10
- 235000019286 ammonium lactate Nutrition 0.000 claims abstract description 10
- RZOBLYBZQXQGFY-HSHFZTNMSA-N azanium;(2r)-2-hydroxypropanoate Chemical compound [NH4+].C[C@@H](O)C([O-])=O RZOBLYBZQXQGFY-HSHFZTNMSA-N 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 22
- 239000006185 dispersion Substances 0.000 claims description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 9
- 239000008213 purified water Substances 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 230000002829 reductive effect Effects 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 238000004806 packaging method and process Methods 0.000 claims description 7
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 6
- 239000004927 clay Substances 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- 239000010696 ester oil Substances 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 239000000049 pigment Substances 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- 229920001285 xanthan gum Polymers 0.000 claims description 6
- 239000000230 xanthan gum Substances 0.000 claims description 6
- 229940082509 xanthan gum Drugs 0.000 claims description 6
- 235000010493 xanthan gum Nutrition 0.000 claims description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 5
- 241000207199 Citrus Species 0.000 claims description 5
- 235000020971 citrus fruits Nutrition 0.000 claims description 5
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims description 5
- 229940075529 glyceryl stearate Drugs 0.000 claims description 5
- 244000005700 microbiome Species 0.000 claims description 5
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 5
- 239000005995 Aluminium silicate Substances 0.000 claims description 4
- 235000012211 aluminium silicate Nutrition 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000003002 pH adjusting agent Substances 0.000 claims description 4
- 229910052613 tourmaline Inorganic materials 0.000 claims description 4
- 229940070527 tourmaline Drugs 0.000 claims description 4
- 239000011032 tourmaline Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000005868 electrolysis reaction Methods 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 150000002500 ions Chemical class 0.000 claims description 3
- 239000008399 tap water Substances 0.000 claims description 3
- 235000020679 tap water Nutrition 0.000 claims description 3
- 235000005687 corn oil Nutrition 0.000 claims description 2
- 239000002285 corn oil Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000005498 polishing Methods 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 abstract description 10
- 230000007803 itching Effects 0.000 abstract description 9
- 210000003491 skin Anatomy 0.000 description 49
- 230000000694 effects Effects 0.000 description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 230000003020 moisturizing effect Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 241000208340 Araliaceae Species 0.000 description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 235000008434 ginseng Nutrition 0.000 description 5
- 210000002374 sebum Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000004264 Petrolatum Substances 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 229940066842 petrolatum Drugs 0.000 description 4
- 235000019271 petrolatum Nutrition 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 241001444063 Aronia Species 0.000 description 3
- 206010003645 Atopy Diseases 0.000 description 3
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- 230000037336 dry skin Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 210000001061 forehead Anatomy 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 3
- 229940033329 phytosphingosine Drugs 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 230000036620 skin dryness Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000020411 cell activation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000000366 juvenile effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Chemical class O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- 241001400472 Omiza Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940040563 agaric acid Drugs 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical class O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000035597 cooling sensation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- DGVMNQYBHPSIJS-UHFFFAOYSA-N dimagnesium;2,2,6,6-tetraoxido-1,3,5,7-tetraoxa-2,4,6-trisilaspiro[3.3]heptane;hydrate Chemical compound O.[Mg+2].[Mg+2].O1[Si]([O-])([O-])O[Si]21O[Si]([O-])([O-])O2 DGVMNQYBHPSIJS-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000007970 homogeneous dispersion Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- -1 oleic saponin Chemical class 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 229910052604 silicate mineral Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/723—Xanthans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- Y10S514/859—
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 여드름 치료에 효능이 있는 로션 제조방법에 관한 것으로, 보다 상세하게는 젖산암모늄을 활용하여 건조하고 거친 피부 및 심상성 어린선(lchthyosis Vulgaris)을 완화시켜 피부 가려움 및 여드름 치료에 효능이 있는 로션 제조방법에 관한 것이다.The present invention relates to a method for producing a lotion which is effective for the treatment of acne, and more particularly, to a method for producing a lotion which is effective for treating skin itching and acne by alleviating dry and rough skin and lchthyosis vulgaris by utilizing ammonium lactate. And to a method for manufacturing lotions.
Description
본 발명은 여드름 치료에 효능이 있는 로션 제조방법에 관한 것으로, 보다 상세하게는 젖산암모늄을 활용하여 건조하고 거친 피부 및 심상성 어린선(lchthyosis Vulgaris)을 완화시켜 피부 가려움 및 여드름 치료에 효능이 있는 로션 제조방법에 관한 것이다.The present invention relates to a method for producing a lotion which is effective for the treatment of acne, and more particularly, to a method for producing a lotion which is effective for treating skin itching and acne by alleviating dry and rough skin and lchthyosis vulgaris by utilizing ammonium lactate. And to a method for manufacturing lotions.
잘 알려진 바와 같이, 섭생의 부조화, 약물, 수술, 음식, 환경여건, 화학적 물리적 요인, 압력, 온도, pH 등의 변화로 인해 세포가 손상을 받거나 기능저하에 놓일 경우, 세포내 미토콘드리아(mitochondria)에서의 ATP 발생량이 줄어든다.As is well known, when cells are damaged or deteriorated due to changes in regulation, medication, surgery, food, environmental conditions, chemical and physical factors, pressure, temperature, pH, etc., mitochondria Of ATP is reduced.
이때, 심부온도(Core temperature)가 저하되어 체온조절 중추인 시상하부(hypothalamus)에서는 체온을 보존, 유지하기 위해 모공을 닫아서 땀의 배출을 줄이게 된다.At this time, the core temperature is lowered, and in the hypothalamus, which is the central body of temperature control, the pores are closed to reduce sweat discharge to preserve and maintain the body temperature.
그런데, 모공이 닫힌 상태에서 일상적인 일, 과도한 업무, 스트레스, 식사, 운동 등을 하면서 생활하게 되면 피부로의 수분공급량이 줄어들어 피부가 논바닥이나 물고기 비늘처럼 갈라지게 되는데, 이런 현상이 피부에서 심중하게 발생하면 심상성 어린선(lchthyosis Vulgaris)이라고 진단을 내리게 된다.However, when the pores are closed, the daily work, the excessive work, the stress, the meal, the exercise, etc., are reduced, and the skin is reduced as the water is supplied to the skin. As a result, When it occurs, it is diagnosed as lchthyosis Vulgaris.
이러한 심상성 어린선은 결국 피부가 건조한 것으로부터 시작되며, 가려움증을 동반하게 된다.These imaginary lines begin with dry skin and eventually itch.
이와 관련하여 피레토세라피라는 의학적 치료가 행해지고 있는데, 이는 심부의 온도는 상승시키고 피부온도는 하강시키며 모공개폐를 원활하게 하는 것이 주요 개념이다.In this regard, a medical treatment called pereethetherapy is being carried out, which is the main concept of increasing the temperature of the deep part, lowering the skin temperature and smoothing the pore opening and closing.
이와 함께, 약물요법, 식이요법, 생활요법, 운동요법이 곁들여지고 있으나 이는 전문가를 통해 집중적이고 지속적인 관리를 통해야만 가능하므로 시간에 쫓기는 바쁜 일상과 공기질이 나쁜 환경속에 노출된 상태로 살아가야 하는 현대인에게는 극심한 고통이 동반되지 않는 한 행하기 어려운 치료법이다.In addition, medication therapy, diet, lifestyle therapy and exercise therapy are accompanied by professional and intensive and continuous management is possible only through time, busy daily life, Is a difficult treatment to treat unless accompanied by extreme pain.
때문에, 일반인이 바쁜 일상속에서도 쉽게 접하고 사용할 수 있는 로션 형태의 피부보습제들이 많이 개발되어 시판중에 있다.Therefore, many lotion type skin moisturizers that can be easily contacted and used even in the busy daily life of the general public have been developed and on the market.
하지만, 이들은 피부 보습 기능에 그치고 있고, 조금이나마 가려움증을 완화시키고 피부 건조화 저지시간을 연장시키는 효능을 가진 제품의 경우에는 너무 비싸 일반인들에게는 비용부담이 매우 크다는 한계를 가지고 있다.However, they are limited to the skin moisturizing function, and it is too expensive for a product having an effect of alleviating itching and prolonging the time for preventing dryness of the skin, which is a very expensive cost to the general public.
뿐만 아니라, 피부가 건조해지면서 피지선의 활동이 자극받아 과도한 양의 피지가 분비되게 되고, 이것은 여드름 생성과 직접적인 관련을 갖게 된다.In addition, as the skin becomes dry, the activity of the sebaceous glands is stimulated and an excessive amount of sebum is secreted, which is directly related to the generation of acne.
물론, 여드름과 관련해서는 이것 외에도 호르몬 이상, 불규칙한 식습관, 과도한 스트레스 등이 복합적으로 작용하여 발생하기도 하지만, 가장 근본적이고 기본적인 발생 원인은 결국 피부 건조화에 있다고 보아야 한다.Of course, in relation to acne, hormonal abnormalities, irregular eating habits, and excessive stress can also be caused by a complex action. However, the most fundamental and fundamental cause of acne is the skin dryness.
본 발명은 상술한 바와 같은 종래 기술상의 제반 문제점들을 감안하여 이를 해결하고자 창출된 것으로, 젖산암모늄을 활용하여 건조하고 거친 피부 및 심상성 어린선(lchthyosis Vulgaris)을 완화시켜 피부 가려움 및 여드름 치료에 효능이 있는 로션 제조방법을 제공함에 그 주된 목적이 있다.The present invention has been made in view of the above-described problems in the prior art, and it is an object of the present invention to provide a method for treating skin irritation and acne by using ammonium lactate to alleviate dry and rough skin and lchthyosis vulgaris, The present invention is directed to a method for manufacturing a lotion.
본 발명은 상기한 목적을 달성하기 위한 수단으로, 용제인 정제수에 용매인 로션 조성물을 저속으로 혼합시키는 분산단계; 상기 분산단계에서 수득된 분산액을 50-60℃로 가열한 후 실온으로 식혀서 점도를 안정적으로 유지시키는 유화단계; 유화된 유화액에 색소나 광택제, 기능성 안료를 첨가하는 혼합단계; 혼합제조된 로션을 용기에 충전하여 포장하는 포장단계;로 이루어지는 여드름 치료에 효능이 있는 로션 제조방법에 있어서; 상기 분산단계에서, 용제인 정제수에 용매인 로션 조성물이 혼합 분산되어 수득되는 분산액은 젖산암모늄 5중량%, 글리세린 2중량%, 프로필렌글리콜 3중량%, 트레할로스 0.5중량%, 잔탄검 0.2중량%, 1-2㎛의 입도를 갖는 카올린과 몬모릴로라이트를 1:1의 중량비로 혼합한 점토화합물 1중량%, 유화제인 글리세릴스테아레이트 3.5중량%, 에스테르 오일 12중량%, 감귤과피ㆍ복분자ㆍ울금ㆍ산수유를 1:1:1:1의 중량비로 혼합한 상태에서 복합미생물을 첨가하여 발효 후 추출한 다음 동결 건조한 분말상의 복합발효추출물 2중량%, 방부제 0.5중량%, 아로마오일 0.5중량%, pH 조절제 0.5중량% 및 나머지 정제수로 이루어진 것을 특징으로 하는 여드름 치료에 효능이 있는 로션 제조방법을 제공한다.Disclosure of the Invention In order to achieve the above-mentioned object, the present invention provides a method for producing a water-based cosmetic composition, comprising: a dispersion step of mixing a lotion composition as a solvent at low speed; An emulsifying step of heating the dispersion obtained in the dispersing step to 50-60 캜 and cooling to room temperature to keep the viscosity stably; A mixing step of adding a pigment, a brightener and a functional pigment to the emulsified emulsion; A packaging step of filling the mixed lotion with a container and packaging the mixed lotion; In the dispersion step, a dispersion solution obtained by mixing and dispersing a lotion composition as a solvent in a solvent is mixed with 5 wt% of ammonium lactate, 2 wt% of glycerin, 3 wt% of propylene glycol, 0.5 wt% of trehalose, 0.2 wt% of xanthan gum, 1% by weight of a clay compound prepared by mixing kaolin and montmorillonite having a particle size of -2 탆 in a weight ratio of 1: 1, 3.5% by weight of glyceryl stearate as an emulsifier, 12% by weight of ester oil, citrus peel, 2% by weight of complex fermented extract, 0.5% by weight of preservative, 0.5% by weight of aroma oil, 0.5% by weight of pH adjusting agent 0.5% by weight of corn oil, 1: 1: 1: 1 by weight of a mixed microorganism, By weight, and the remaining purified water. The present invention also provides a method for producing an effective lotion for treating acne.
이때, 상기 분산단계에서 사용되는 용제인 정제수는 가열 증류된 증류수를 40-50℃로 가열되고 있는 토르말린 분말과 활석 분말이 2:1의 중량비로 혼합된 여과체를 여과시켜 얻은 여과수 50부피%와; 수돗물을 전기분해하여 얻은 알카리 이온 전해 환원수 50부피%를 혼합하여 이루어진 것에도 그 특징이 있다.At this time, the purified water used as the solvent used in the dispersion step was prepared by mixing distilled water heated at 50-50 ° C with 50% by volume of filtered water obtained by filtering a mixture of tourmaline powder and talc powder mixed at a weight ratio of 2: 1 ; And 50 vol% of alkaline ion electrolytic reduced water obtained by electrolysis of tap water.
또한, 상기 분산단계는 100-200rpm으로 10-15분간 교반하도록 구성되는 것에도 그 특징이 있다.The dispersion step is also characterized in that it is configured to stir at 100-200 rpm for 10-15 minutes.
본 발명에 따르면, 젖산암모늄을 활용하여 건조하고 거친 피부 및 심상성 어린선(lchthyosis Vulgaris)을 완화시켜 피부 보습에 따른 피부 가려움 및 여드름 생성 억제 효과를 얻을 수 있다.According to the present invention, ammonium lactate can be used to alleviate dry and rough skin and lchthyosis vulgaris, and skin itching and acne formation inhibiting effect due to skin moisturization can be obtained.
이하에서는, 본 발명에 따른 바람직한 실시예를 보다 상세하게 설명하기로 한다.Hereinafter, preferred embodiments according to the present invention will be described in detail.
본 발명 설명에 앞서, 이하의 특정한 구조 내지 기능적 설명들은 단지 본 발명의 개념에 따른 실시예를 설명하기 위한 목적으로 예시된 것으로, 본 발명의 개념에 따른 실시예들은 다양한 형태로 실시될 수 있으며, 본 명세서에 설명된 실시예들에 한정되는 것으로 해석되어서는 아니된다.Before describing the present invention, the following specific structural or functional descriptions are merely illustrative for the purpose of describing an embodiment according to the concept of the present invention, and embodiments according to the concept of the present invention may be embodied in various forms, And should not be construed as limited to the embodiments described herein.
또한, 본 발명의 개념에 따른 실시예는 다양한 변경을 가할 수 있고 여러 가지 형태를 가질 수 있으므로, 본 발명의 사상 및 기술 범위에 포함되는 모든 변경물, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다.In addition, it should be understood that the embodiments according to the concept of the present invention include various modifications, equivalents, and alternatives included in the spirit and technical scope of the present invention, .
본 발명에 따른 여드름 치료에 효능이 있는 로션 제조방법은 용제인 정제수에 용매인 로션 조성물을 저속으로 혼합시키는 분산단계; 상기 분산단계에서 수득된 분산액을 50-60℃로 가열한 후 실온으로 식혀서 점도를 안정적으로 유지시키는 유화단계; 유화된 유화액에 필요한 색소나 광택제, 기능성 안료를 첨가하는 혼합단계; 혼합제조된 로션을 용기에 충전하여 포장하는 포장단계;로 이루어진다.A method for preparing a lotion having efficacy for treating acne according to the present invention comprises: a dispersion step of mixing a lotion composition as a solvent at low speed into purified water as a solvent; An emulsifying step of heating the dispersion obtained in the dispersing step to 50-60 캜 and cooling to room temperature to keep the viscosity stably; A mixing step of adding a pigment, a brightener and a functional pigment necessary for the emulsified emulsion; And a packaging step of filling the mixed lotion into a container and packaging the mixed lotion.
이때, 상기 분산단계에서 사용되는 용제인 정제수는 가열 증류된 증류수를 40-50℃로 가열되고 있는 토르말린 분말과 활석 분말이 2:1의 중량비로 혼합된 여과체를 여과시켜 얻은 여과수 50부피%와; 수돗물을 전기분해하여 얻은 알카리 이온 전해 환원수, 즉 알카리이온수 50부피%를 혼합하여 이루어진 것을 사용한다.At this time, the purified water used as the solvent used in the dispersion step was prepared by mixing distilled water heated at 50-50 ° C with 50% by volume of filtered water obtained by filtering a mixture of tourmaline powder and talc powder mixed at a weight ratio of 2: 1 ; An electrolytic reduced water of alkaline ion obtained by electrolysis of tap water, that is, 50 vol% of alkaline ionized water is used.
여기에서, 토르말린은 규산염 광물로서, 세포 활성화, 피부 및 점막 강화, 가려움증 해소, 피부트러블 억제, 항산화 기능을 갖는 셀레늄, 마그네슘, 붕소, 규소, 은 등이 함유되어 있어 피부 진정, 소염 작용에 기여하기 위해 사용되며; 활석은 단사정계 염기성 규산마그네슘광물로서, 피부점막보호, 해독, 소염 기능을 구현하기 위해 첨가되며 특히, 과도한 피부 보습이 생기지 않도록 하기 위해 첨가된다.Here, tourmaline is a silicate mineral that contains selenium, magnesium, boron, silicon, and silver, which have cell activation, skin and mucous strengthening, relieve itching, inhibit skin troubles and antioxidants. Used for; Talc is a monoclinic basic magnesium silicate mineral which is added to achieve skin mucosal protection, detoxification and anti-inflammatory function, in particular to prevent excessive skin moisturization.
또한, 알카리이온수는 체내 혈액이 약알카리성을 띠고 있기 때문에 흡수가 빠르고, 피부에 미네랄 등을 공급하여 습윤상태로 유지하는 효과적이기 때문에 본 발명에서 사용된다.Alkali ionized water is used in the present invention because blood in the body is weakly alkaline, and therefore, absorption is rapid and it is effective to supply minerals and the like to the skin to keep the skin moist.
아울러, 상기 용매인 로션 조성물은 젖산암모늄, 글리세린, 프로필렌글리콜, 트레할로스, 잔탄검, 점토화합물, 유화제, 에스테르 오일, 복합발효추출물, 방부제, 아로마오일, pH 조절제로 이루어지며; 용제인 정제수에 용매인 로션 조성물이 혼합 분산된 분산액은 젖산암모늄 5중량%, 글리세린 2중량%, 프로필렌글리콜 3중량%, 트레할로스 0.5중량%, 잔탄검 0.2중량%, 1-2㎛의 입도를 갖는 카올린과 몬모릴로라이트를 1:1의 중량비로 혼합한 점토화합물 1중량%, 유화제인 글리세릴스테아레이트 3.5중량%, 에스테르 오일 12중량%, 감귤과피ㆍ복분자ㆍ울금ㆍ산수유를 1:1:1:1의 중량비로 혼합한 상태에서 복합미생물을 첨가하여 발효 후 추출한 다음 동결 건조한 분말상의 복합발효추출물 2중량%, 방부제 0.5중량%, 아로마오일 0.5중량%, pH 조절제 0.5중량% 및 나머지 정제수로 이루어진다.In addition, the lotion composition as a solvent is composed of ammonium lactate, glycerin, propylene glycol, trehalose, xanthan gum, clay compound, emulsifier, ester oil, complex fermentation extract, preservative, aroma oil and pH regulator; The dispersion in which the lotion composition as a solvent is mixed and dispersed in the solvent is composed of 5 wt% of ammonium lactate, 2 wt% of glycerin, 3 wt% of propylene glycol, 0.5 wt% of trehalose, 0.2 wt% of xanthan gum, 1% by weight of a clay compound prepared by mixing kaolin and montmorillarite in a weight ratio of 1: 1, 3.5% by weight of glyceryl stearate as an emulsifier, 12% by weight of an ester oil, citrus peels, : 1, the complex microorganism was added and the mixture was extracted after fermentation, and then the mixture was composed of 2% by weight of the combined fermented extract of lyophilized powder, 0.5% by weight of preservative, 0.5% by weight of aroma oil, 0.5% .
이때, 상기 젖산암모늄(Ammonium Lactate)은 젖산에 암모늄을 첨가한 후 산화되는 것을 중화시켜 젖산 본래의 기능을 극대화시킨 합성물질로서, 천연보습기능이 뛰어난 젖산을 함유하고 있어 건선피부, 특히 심상성 어린선, 아토피, 피부 건조증에 탁월한 보습 효능을 제공한다.Ammonium lactate is a synthetic substance that maximizes the original function of lactic acid by neutralizing the oxidized lactic acid by adding ammonium to lactic acid and contains lactic acid having excellent natural moisturizing function, Provides excellent moisturizing effect for sun, atopy and dry skin.
본 발명에서는 18℃에서 빨리 녹고 대기로부터 습기를 빠르게 흡수하는 성질과 피부 흡수력이 빠른 특성을 이용하여 피부 건조억제 기능 강화를 위해 5중량%의 범위로 첨가 사용한다.In the present invention, 5% by weight is added in order to enhance skin dryness inhibition by rapidly melting at 18 DEG C and rapidly absorbing moisture from the atmosphere and rapidly absorbing the skin.
그리고, 상기 글리세린은 유지성분을 포함하는 습윤제로서, 공기중의 수분을 흡수하여 피부에 수분을 보급하는 역할을 담당하여 건조한 피부를 윤기있게 보습함으로써 피지 발생량을 줄여 여드름 발생을 억제하기 위해 첨가된다. 이를 위해, 본 발명에서는 2중량% 범위로 첨가하여야 하는데 이를 초과하여 과량 첨가하게 되면 오히려 피부에서 수분이 빠져나가는 역효과가 발생하므로 상기 범위로 한정해야 한다.The glycerin is a wetting agent containing a fat component. The glycerin absorbs moisture in the air and replenishes moisture to the skin, thereby moisturizing the dry skin and thereby reducing sebum production thereby suppressing the occurrence of acne. For this, in the present invention, it is added in the range of 2 wt%. If it is added in an excess amount in excess of 2 wt%, the adverse effect of moisture escaping from the skin occurs.
또한, 상기 프로필렌글리콜은 글리세린을 과량 첨가할 수 없기 때문에 이를 보조하면서 곰팡이 번식을 억제하고 방부성도 갖도록 하기 위해 첨가된다. 다만, 3중량%를 초과할 경우 피부 자극을 유발할 수 있기 때문에 상기 범위로 한정해야 한다.In addition, the propylene glycol is added in order to suppress the growth of fungi and to impart antimicrobial properties while supporting excess of glycerin. However, if it exceeds 3% by weight, skin irritation may be caused, so that it should be limited to the above range.
아울러, 상기 트레할로스(Trehalose)는 이당류에 속하는 물질로서, 피부의 단백질, 지질 등의 분자를 안정화시키면서 수분을 매우 강하게 간직시키는 보수화기능을 위해 첨가된다. 다만, 감미질이 뛰어나기 때문에 0.5중량%를 초과하여 첨가하지 않는 것이 바람직하다.In addition, Trehalose belongs to the disaccharide, and is added for the purpose of preserving the moisture of the skin such as protein, lipid and the like while keeping the moisture very strong. However, it is preferable to not add more than 0.5 wt.
뿐만 아니라, 상기 잔탄검(Xanthan Gum)은 발효시켜서 얻은 고분자다당류 검물질을 이소프로필알코올에 정제한 후 건조, 분쇄한 포도당, 만노스 및 글루쿠론산의 나트륨, 칼륨 및 칼슘염 등을 포함하는 혼합물이다. 본 발명에서는 계면활성 및 유화성을 가지면서 피부컨티셔닝을 위해 미량 첨가된다. 즉, 0.2중량%를 초과하면 점도가 크게 높아져 용액화를 저해하므로 상기 범위로 첨가하여야 한다.In addition, the Xanthan Gum is a mixture containing glucose, mannose, and sodium, potassium and calcium salts of mannose and glucuronic acid after purifying the polymer polysaccharide gum obtained by fermentation into isopropyl alcohol, followed by drying and pulverization . In the present invention, a minor amount of surfactant and emulsifying agent are added for skin conditioning. That is, when the content exceeds 0.2% by weight, the viscosity is greatly increased to inhibit solubilization.
그리고, 상기 점토화합물은 미세한 입자(1-2㎛)이면서 부드럽고 하얀색상 구현에 적당한 규산염의 일종인 카올린과 몬모릴로라이트를 1:1의 중량비로 혼합한 것으로 사용하며, 특히 몬모릴로라이트의 경우 원적외선 방사에 따른 피부내 세포를 활성화시켜 피지 생성을 억제하고 피부가 건조화되어 심상성 어린선으로 변하는 것을 차단하는 기능을 위해 첨가된다.The clay compound is a mixture of kaolin and montmorillonite in a weight ratio of 1: 1, which is a kind of silicate, which is a fine particle (1-2 탆) and suitable for smooth and white color development. In particular, in the case of montmorillonite, It is added for the function of activating the cells in the skin by radiation to inhibit sebaceous formation and to prevent the skin from drying out and turning into imaginary young lines.
또한, 상기 유화제는 서로 혼합되지 않는 두 종류의 액체를 안정한 에멀젼(유탁액)으로 만드는 물질로서, 글리세릴스테아레이트가 바람직하다. 다만, 3.5중량%를 초과하면 에멀젼이 과도하게 형성되므로 상기 범위로 한정하여야 한다.In addition, the above-mentioned emulsifier is preferably a substance which makes two kinds of liquids which are not mixed with each other into a stable emulsion (emulsion), and glyceryl stearate. However, if it exceeds 3.5% by weight, the emulsion will be excessively formed, so that it should be limited to the above range.
아울러, 상기 에스테르 오일은 보습겸 피부 코팅제로서 피부에 영향을 공급한 상태에서 습윤상태로 피막을 형성함으로써 피부건선을 막아 피지 발생을 억제하고, 이를 통해 여드름 발생을 차단하면서 가려움증을 해소하는 기능을 담당한다. 다만, 12중량%를 초과하면 피부 유연화를 저해하므로 상기 범위로 한정하여 사용해야 한다.In addition, the ester oil is a moisturizing and skin coating agent, which forms a film in a moist state in a state of supplying an influence to the skin, thereby suppressing the occurrence of sebum by blocking skin psoriasis, thereby preventing the occurrence of acne and preventing itching do. However, if it is more than 12% by weight, skin softening is inhibited, and therefore, the use should be limited to the above range.
뿐만 아니라, 상기 복합발효추출물은 피부 진정효과를 위해 첨가되는 것으로, 감귤과피, 복분자, 울금, 산수유를 1:1:1:1의 중량비로 혼합한 상태에서 복합미생물을 첨가하여 발효 후 추출한 다음 동결 건조한 분말상의 천연식물성 발효추출물이다.In addition, the complex fermentation extract is added for skin soothing effect, and the complex microorganism is added in a weight ratio of 1: 1: 1: 1 of citrus peel, bokbunja, It is a natural vegetable fermented extract in a dry powder form.
또한, 상기 방부제는 방부성을 위해 미량 첨가되는 것으로 이미다졸리디닐우레아가 바람직하며, 상기 아로마오일은 식물성 오일로서 피부 표면으로 올라온 수분이 증발되면서 건조화를 초래하고 습윤 상태를 나쁘게 하는 것을 억제하기 위해 첨가되고, 상기 pH 조절제는 산도를 조절하기 위해 첨가되는 일종의 완충제로서 약알카리성인 트리에탄올아민(Triethanolamine)이 바람직하다.In addition, the preservative is added in a trace amount for the purpose of preservation, and imidazolidinyl urea is preferable. The aroma oil is a vegetable oil and is added as a vegetable oil in order to prevent the moisture coming from the skin surface from evaporating, And triethanolamine, which is a weakly alkaline buffering agent, is added to adjust the pH of the pH adjusting agent.
이에 더하여, 기능성을 더 구현하기 위해 상기 분산액에는 상기 정제수 100중량부에 대해, 수경인삼 분말(0.1-0.2㎛) 2중량부, 아로니아 분말(0.1-0.2㎛) 2중량부, 이소프로필미리스테이트 2중량부, 페트롤라툼 1.5중량부, 카보머 0.5중량부, 생클로 추출수 5중량부, 피토스핀고신 3중량부를 더 첨가할 수 있다.In addition, to further realize the functionality, 2 parts by weight of water-based ginseng powder (0.1-0.2 mu m), 2 parts by weight of Aronia powder (0.1-0.2 mu m), 2 parts by weight of isopropyl myristate 2 parts by weight of petrolatum, 1.5 parts by weight of petrolatum, 0.5 part by weight of carbomer, 5 parts by weight of raw chloe extract and 3 parts by weight of phytosphingosine.
이때, 상기 수경인삼 분말은 인삼을 수경재배한 것을 찐 다음 건조시킨 후 분말화한 것으로, 토경재배에 비해 연작이 가능하고 오염이 없어 청정한 상태로 친환경적인 재배가 가능하며, 사포닌 함량이 뿌리는 14.3-15.8mg/g, 잎은 140.8-180mg/g으로서 근경에 비해 무려 9배가 높고, 비타민C가 65.9mg/g 이상 함유되어 있어 잎, 줄기, 뿌리 모두를 사용할 수 있는 잇점이 있다.In this case, the water-based ginseng powder is obtained by hydroponically cultivating ginseng and then drying and pulverizing it. It is possible to make a series as compared with the cultivation of the soil, and it is possible to cultivate environmentally friendly without pollution and saponin content is 14.3 -15.8mg / g, and the leaf is 140.8-180mg / g, which is 9 times higher than rhizome, and contains vitamin C of 65.9mg / g or more, so that it is possible to use all of leaves, stems and roots.
특히, 사포닌은 식물계에 분포하며 트리타르펜과 스테로이드를 아글리콘으로하는 배당체의 총칭으로서, 인삼에는 22종의 사포닌이 함유된 것으로 알려져 있고, 이 중에서도 Rh2 진세노사이드와 Rh1 진세노사이드는 피부면역 강화 및 진정효과가 뛰어나 아토피 진정기능이 우수한 것으로 알려져 있고, 또한 올레아닌계 사포닌은 열을 내려 피부 진정 효과를 강화시키며, 면역력도 강화시키는 것으로 알려져 있다.Especially, saponin is a generic name of glycosides containing agaric acid as a triglypene and steroid distributed in the vegetable field. It is known that ginseng contains 22 kinds of saponin. Among them, Rh2 ginsenoside and Rh1 ginsenoside have skin immunity It is known that it has excellent strengthening and soothing effect and is excellent at atopy sedative function. Moreover, oleic saponin is known to enhance heat retention, skin soothing effect and immunity.
그리고, 상기 아로니아(Aronia)는 장미과(Rosaceae)의 낙엽관목으로 폴리페놀 및 안토시아닌의 함량이 매우 높아 항산화력(ORAC:Oxygen Radical Absorbent Capacity 기준) 역시 매우 우수하며, 열매는 피부 항산화 효과, 콜라겐 합성효과, 피부 잔주름 완화효과, 여드름 방지효과 및 염증완화 효과를 측정한 결과 우수함이 보고된 바 있다.The Aronia is a deciduous shrub of Rosaceae and has a very high content of polyphenols and anthocyanins, and thus has excellent antioxidant capacity (ORAC: Oxygen Radical Absorbent Capacity). The fruit has a skin antioxidant effect, collagen synthesis The effect of reducing skin wrinkles, the effect of preventing acne and the effect of reducing inflammation have been reported to be excellent.
또한, 상기 이소프로필미리스테이트(Isopropyl Myristate)는 이소프로필알콜과 미리스틱애씨드의 에스터로서 유연성을 제공하기 위해 첨가되며; 상기 페트롤라툼(petrolatum)은 비결정성인 고체탄화수소를 주성분으로 하는 흰색 연고모양의 물질로서 방수 기능이 있어 피부에 피막을 형성함으로써 피부를 보호하기 위해 첨가되고; 상기 카보머(Cabomer)는 피부에 청량감을 주기 위해 첨가된다.In addition, the isopropyl myristate is added to provide flexibility as an ester of isopropyl alcohol and myristic acid; The petrolatum is a white ointment-like substance composed mainly of amorphous solid hydrocarbons and is waterproof and added to protect the skin by forming a film on the skin; The carbomer is added to give skin a cooling sensation.
아울러, 상기 생클로(Live Chlorella)는 담수에 살고 있는 플랑크톤의 한 종류로서, 직경 2-10㎛ 크기의 단세포 생물임에도 불구하고 일반식물보다 매우 많은 엽록소를 가지고 있어 광합성작용이 활발하며, 하루에도 4-8분열하여 55%의 고급단백질과 인체에 필수적인 5대 영양소는 물론 섬유질, 필수아미노산이 풍부하고, C.G.F라는 성장촉진인자를 다량으로 함유하고 있는 생물이다.In addition, Live Chlorella is a kind of plankton living in freshwater. Although it is a single-celled organism with a diameter of 2-10 μm, it has much more chlorophyll than ordinary plants, and its photosynthesis activity is active. -8 divided into 55% of high-quality protein and nutrients essential to the human body, as well as fiber, essential amino acids are abundant, CGF is a creature that contains a large amount of growth-promoting factors.
이와 같은 생클로는 육류의 지방분해와 당분해 능력이 뛰어나 세포활성화를 촉진하므로 인체의 면역력을 강화시키고, 중금속과 독소 중화능력을 갖추고 있다. 다만, 단순 첨가는 어렵고 추출수 첨가방식을 통해 안전성을 높이도록 구성되어야 하는데, 생클로 추출수를 생성하는 방법은 생클로를 정제수에 침지한 상태로 8-10시간 방치한 후 압착 여과하는 형태로 이루어진다.Such raw chlo is excellent in fat decomposition and sugar disinfection ability of meat and promotes cell activation, thus enhancing the immunity of the human body, and has the ability to neutralize heavy metals and toxins. However, simple addition is difficult, and it should be constructed so as to increase the safety through the addition of the extractive water addition method. As a method of generating the raw chloe extract water, the raw chloe is left in the purified water for 8-10 hours, .
그리고, 상기 피토스핀고신은 생체 지질과 유사한 구조의 지질로서 여드름 발생 억제에 따른 피부손상을 방지하고 피부 장벽효과를 높여 감염을 억제하도록 하기 위해 첨가된다.The above-mentioned phytosphingosine is a lipid having a structure similar to bio-lipid, which is added in order to prevent skin damage due to the inhibition of acne occurrence and increase the skin barrier effect to inhibit infection.
한편, 상기 분산단계는 저속으로 교반되어야 하는데, 균질한 분산액 구성을 위해 100-200rpm으로 10-15분간 교반하도록 함이 바람직하다.On the other hand, the dispersion step should be stirred at a low speed, and it is preferable to stir at 100-200 rpm for 10-15 minutes in order to form a homogeneous dispersion.
이후, 분산액은 상술한 유화단계, 혼합단계, 포장단계를 거쳐 제품화되게 된다.Thereafter, the dispersion is commercialized through the above-described emulsification step, mixing step, and packaging step.
이때, 유화단계에서 50-60℃로 가열하는 이유는 수용성 물질중 미용해 성분이 생기지 않도록 하면서 유화를 촉진하기 위한 것이다.In this case, the reason for heating to 50-60 占 폚 in the emulsification step is to promote emulsification while preventing the undissolved components from occurring in the water-soluble substance.
이하, 실시예에 대하여 설명한다.Hereinafter, examples will be described.
[실시예 1][Example 1]
본 발명에 따른 제조방법으로 로션을 만들되, 분산액은 젖산암모늄 5중량%, 글리세린 2중량%, 프로필렌글리콜 3중량%, 트레할로스 0.5중량%, 잔탄검 0.2중량%, 1-2㎛의 입도를 갖는 카올린과 몬모릴로라이트를 1:1의 중량비로 혼합한 점토화합물 1중량%, 유화제인 글리세릴스테아레이트 3.5중량%, 에스테르 오일 12중량%, 감귤과피ㆍ복분자ㆍ울금ㆍ산수유를 1:1:1:1의 중량비로 혼합한 상태에서 복합미생물을 첨가하여 발효 후 추출한 다음 동결 건조한 분말상의 복합발효추출물 2중량%, 방부제 0.5중량%, 아로마오일 0.5중량%, pH 조절제 0.5중량% 및 나머지 정제수로 조성하였다.The lotion is made by the manufacturing method according to the present invention, wherein the dispersion contains 5 wt% of ammonium lactate, 2 wt% of glycerin, 3 wt% of propylene glycol, 0.5 wt% of trehalose, 0.2 wt% of xanthan gum, 1: 1: 1: 1 mixture of 1% by weight of a clay compound obtained by mixing 1: 1 and montmorillonite in a weight ratio of 1: 1, 3.5% by weight of glyceryl stearate as an emulsifier, 12% by weight of an ester oil, citrus peels, 1, the complex microorganism was added, followed by extraction after fermentation. The resulting mixture was then lyophilized to prepare 2% by weight of complex fermented extract, 0.5% by weight of preservative, 0.5% by weight of aroma oil, 0.5% by weight of pH adjusting agent and remaining purified water .
[실시예 2][Example 2]
실시예 1과 동일하게 하되, 상기 정제수 100중량부에 대해, 수경인삼 분말(0.1-0.2㎛) 2중량부, 아로니아 분말(0.1-0.2㎛) 2중량부, 이소프로필미리스테이트 2중량부, 페트롤라툼 1.5중량부, 카보머 0.5중량부, 생클로 추출수 5중량부, 피토스핀고신 3중량부를 상기 분산액에 더 첨가하였다.2 parts by weight of water-based ginseng powder (0.1 to 0.2 mu m), 2 parts by weight of Aronia powder (0.1 to 0.2 mu m), 2 parts by weight of isopropyl myristate, 1.5 parts by weight of petrolatum, 0.5 parts by weight of carbomer, 5 parts by weight of raw chloe extract and 3 parts by weight of phytosphingosine were further added to the above dispersion.
그리고, 본 발명에 따른 로션이 여드름 및 심상성 어린선 완화에 효과가 있는지를 확인하기 위해 18-20세 청소년 40명(남자 20명, 여자 20명)을 선정하여 이들을 대상으로 1일 3회씩 상기 로션을 환부에 바르고, 환부에서의 변화를 2개월간 확인하였다. 특히, 비교를 위해 시판중인 피부보습제인 '아비노 스킨 릴리프 바디로션 354㎖(한국존슨앤드존슨, 2016년 제조)'를 비교예로 나누어 발랐다.In order to confirm whether or not the lotion according to the present invention is effective in alleviating acne and juvenile acne, 40 juveniles (20 males and 20 females) aged 18 to 20 years were selected, The lotion was applied to the affected part and the change in the affected part was confirmed for 2 months. Especially, for comparison, 'Avino Skin Relief Body Lotion 354ml (Korea Johnson & Johnson, manufactured in 2016)', a commercially available skin moisturizer, was divided into comparative examples.
이때, 여드름 및 심상성 어린선의 개선 효과 측정은 40명 전원에 대한 기준 환부(이마, 등, 코)에 대한 기준 영상을 촬상하여 저장하고, 2개월 경과 후 40명 모두의 기준 환부를 다시 촬상한 후 3차원 영상분석법을 통해 기준 영상과 비교 영상을 마이크로단위로 비교 분석하였다. 물론, 매일의 피부 상태는 목측으로도 확인하고 변화 여부를 기록하였다. 이 경우, 이마에는 실시예 1의 로션을 바르고, 등에는 비교예를 발랐으며, 코에는 실시예 2의 로션을 발랐다.At this time, the improvement effect of the acne and the imaginary line was photographed and stored as a reference image for the reference lesion (forehead, back, nose) of 40 persons, and after 2 months, the reference lesion of all 40 persons was imaged again After 3 - dimensional image analysis, the reference image and the comparative image were compared and analyzed on a micro scale. Of course, daily skin conditions were also confirmed by the eye and recorded as changes. In this case, the lotion of Example 1 was applied to the forehead, the comparative example was applied to the back, and the lotion of Example 2 was applied to the nose.
여기에서, 3차원 영상분석법은 머신 비젼 알고리즘(Machine Vision Algorism)을 통해 환부의 명암 패턴, 여드름 및 심상성 어린선의 형태변화를 마이크로단위까지 측정하는 형태로 진행되는 공지의 분석방법이다.Here, 3D image analysis is a well-known method of analyzing the changes in the shape of the contour pattern, acne, and imaginary lines of the lesion to the micro-scale through the Machine Vision Algorithm.
분석 결과, 실시예 1,2의 로션을 바른 이마와 코에서는 피지 발생이 현저히 줄어 여드름 발생이 완화됨을 확인하였고, 또한 피부 건조증이 완화되어 피부 갈라짐(심상성 어린선)이 현저히 줄어드는 것도 확인하였다.As a result of analysis, it was confirmed that occurrence of sebum was significantly reduced in the forehead and nose of the lotions of Examples 1 and 2, and occurrence of acne was alleviated, and it was also confirmed that the skin dryness was alleviated and the skin cracks (imaginary lining) were remarkably reduced.
반면, 비교예를 바른 등의 경우에는 일반적인 보습 기능 외에 치료 개선 효과 없어 여드름 개선이 발견되지 않았고, 여자 3명, 남자 5명의 경우에는 등 일부가 짓무르면서 고름이 생기는 현상도 발견되었다.On the other hand, in the case of the comparative example, in addition to the general moisturizing function, the improvement of the treatment was not effective and the improvement of acne was not found. In the case of 3 women and 5 men,
또한, 피부트러블의 발생 유무를 확인하기 위해, 피부 첩포시험을 통해 로션의 안정성을 테스트하였다.In addition, in order to confirm the occurrence of skin trouble, the stability of lotion was tested through a skin patch test.
이때, 시험대상은 앞서 설명한 시험군 40명을 여드름 및 심상성 어린선 변화관찰 시험시 동시에 테스트하였으며, 실시예1,2 및 비교예의 로션을 피부에 첩포한 후 24시간이 지난 다음 첩포 부위의 피부자극 정도를 관능시험으로 판정하였다.At this time, the test subjects were tested at the same time in the test group of the above-mentioned test group 40 in the test of the acne and dermal tenderness change, and after the lotion of Examples 1, 2 and Comparative Example was applied to the skin for 24 hours, The degree of stimulation was determined by a sensory test.
판정 기준은 피부자극이 전혀 없는 경우를 0, 심한 경우를 5로 하여 상대적인 관능값의 평균을 기재하였는 바, 그 결과 실시예 1,2의 경우에는 피부자극이 0.5, 0.6으로 극히 작게 나타났으나, 비교예의 경우에는 2.5로 비교적 크게 나타났다.As a result, the average of the sensory scores of the skin was 0, 0, and 5, respectively. As a result, skin irritation was extremely small at 0.5 and 0.6 in Examples 1 and 2 , And 2.5 for the comparative example.
또한, 첩포 부위에서 염증, 발진, 홍반, 가려움이 생기는지 육안으로 확인하였으나, 실시예 1,2는 모두 염증, 발진, 홍반, 가려움이 발생하지 않았다. 다만, 비교예의 경우에는 여성 4명이 피부 부풀어오름과 가려움을 동반하였다.In addition, although it was visually confirmed whether inflammation, rash, erythema and itching occurred in the patch area, no inflammation, rash, erythema or itching occurred in Examples 1 and 2. However, in the case of the comparative example, four women were accompanied by skin swelling and itching.
이와 같은 평가결과를 통해, 본 발명에 따른 로션이 여드름과 심상성 어린선을 근본적으로 치료할 수는 없지만, 환부 주변을 보습시켜 습윤상태로 만들고 피부 세포를 활성화시킴으로서 피지의 과도한 분비를 막고, 피부 건조화를 억제하여 피부를 진정시키면서 여드름과 심상성 어린선을 완화시키는 것을 알 수 있었다.Through such evaluation results, although the lotion according to the present invention can not fundamentally cure acne and juvenile glands, it moisturizes the area around the affected area and activates the skin cells to prevent excessive secretion of sebum, To calm the skin and to alleviate acne and imaginary lines.
Claims (3)
상기 분산단계에서, 용제인 정제수에 용매인 로션 조성물이 혼합 분산되어 수득되는 분산액은 젖산암모늄 5중량%, 글리세린 2중량%, 프로필렌글리콜 3중량%, 트레할로스 0.5중량%, 잔탄검 0.2중량%, 1-2㎛의 입도를 갖는 카올린과 몬모릴로라이트를 1:1의 중량비로 혼합한 점토화합물 1중량%, 유화제인 글리세릴스테아레이트 3.5중량%, 에스테르 오일 12중량%, 감귤과피ㆍ복분자ㆍ울금ㆍ산수유를 1:1:1:1의 중량비로 혼합한 상태에서 복합미생물을 첨가하여 발효 후 추출한 다음 동결 건조한 분말상의 복합발효추출물 2중량%, 방부제 0.5중량%, 아로마오일 0.5중량%, pH 조절제 0.5중량% 및 나머지 정제수로 이루어진 것을 특징으로 하는 여드름 치료에 효능이 있는 로션 제조방법.
A dispersion step of mixing the lotion composition as a solvent at low speed with purified water as a solvent; An emulsifying step of heating the dispersion obtained in the dispersing step to 50-60 캜 and cooling to room temperature to keep the viscosity stably; A mixing step of adding at least one of a pigment, a polishing agent and a functional pigment to the emulsified emulsion; A packaging step of filling the mixed lotion with a container and packaging the mixed lotion;
In the dispersion step, a dispersion solution obtained by mixing and dispersing a lotion composition as a solvent in a solvent is mixed with 5 wt% of ammonium lactate, 2 wt% of glycerin, 3 wt% of propylene glycol, 0.5 wt% of trehalose, 0.2 wt% of xanthan gum, 1% by weight of a clay compound obtained by mixing kaolin and montmorillonite having a particle size of -2 탆 in a weight ratio of 1: 1, 3.5% by weight of glyceryl stearate as an emulsifier, 12% by weight of ester oil, citrus peel, 2% by weight of complex fermented extract, 0.5% by weight of preservative, 0.5% by weight of aroma oil, 0.5% by weight of pH adjusting agent 0.5% by weight of corn oil, 1: 1: 1: 1 by weight of a mixed microorganism, By weight, and the remaining purified water.
상기 분산단계에서 사용되는 용제인 정제수는 가열 증류된 증류수를 40-50℃로 가열되고 있는 토르말린 분말과 활석 분말이 2:1의 중량비로 혼합된 여과체를 여과시켜 얻은 여과수 50부피%와; 수돗물을 전기분해하여 얻은 알카리 이온 전해 환원수 50부피%를 혼합하여 이루어진 것을 특징으로 하는 여드름 치료에 효능이 있는 로션 제조방법.
The method according to claim 1,
The purified water used as the solvent used in the dispersion step was prepared by mixing distilled water heated to 50-50 ° C with 50% by volume of filtered water obtained by filtering a mixture of tourmaline powder heated to 40-50 ° C and talc powder in a weight ratio of 2: 1; And 50 vol% of alkaline ion electrolytic reduced water obtained by electrolysis of tap water.
상기 분산단계는 100-200rpm으로 10-15분간 교반하도록 구성되는 것을 특징으로 하는 여드름 치료에 효능이 있는 로션 제조방법.
The method of claim 2,
Wherein the dispersing step is configured to agitate at 100-200 rpm for 10-15 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170003650A KR101736478B1 (en) | 2017-01-10 | 2017-01-10 | Method for manufacturing lotions with effective in treating acne |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170003650A KR101736478B1 (en) | 2017-01-10 | 2017-01-10 | Method for manufacturing lotions with effective in treating acne |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR101736478B1 true KR101736478B1 (en) | 2017-05-29 |
Family
ID=59053279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020170003650A Active KR101736478B1 (en) | 2017-01-10 | 2017-01-10 | Method for manufacturing lotions with effective in treating acne |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR101736478B1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102438804B1 (en) * | 2022-04-22 | 2022-09-01 | 주식회사 아트앤퍼퓸 | Body lotion composition prepared using ginseng oil and frankincense oil for wrinkle improvement and skin aging prevention, and method for preparing the same |
| KR102452738B1 (en) * | 2022-07-05 | 2022-10-11 | 주식회사 서연크린테크 | A handwash composition containing lactic acid bacteria culture product of cactus flower |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0408370B1 (en) | 1989-07-13 | 1995-09-13 | Bristol-Myers Squibb Company | Stable tretinoin emulsified cream formulations |
| US20050036953A1 (en) | 2003-08-13 | 2005-02-17 | Moshe Arkin | Topical compositions of ammonium lactate |
-
2017
- 2017-01-10 KR KR1020170003650A patent/KR101736478B1/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0408370B1 (en) | 1989-07-13 | 1995-09-13 | Bristol-Myers Squibb Company | Stable tretinoin emulsified cream formulations |
| US20050036953A1 (en) | 2003-08-13 | 2005-02-17 | Moshe Arkin | Topical compositions of ammonium lactate |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102438804B1 (en) * | 2022-04-22 | 2022-09-01 | 주식회사 아트앤퍼퓸 | Body lotion composition prepared using ginseng oil and frankincense oil for wrinkle improvement and skin aging prevention, and method for preparing the same |
| KR102452738B1 (en) * | 2022-07-05 | 2022-10-11 | 주식회사 서연크린테크 | A handwash composition containing lactic acid bacteria culture product of cactus flower |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101460969B1 (en) | Skin Cosmetic Composition | |
| WO2002047656A1 (en) | Compositions for retarding skin aging | |
| JPH1045615A (en) | Plant extract-containing fibroblast growth promoter | |
| KR20180118409A (en) | Nutrition Cream Containing Ergothioneine and Its Manufacturing Method | |
| KR101780863B1 (en) | Cosmetic Composion for Acne Improvement Containing Butanol Fraction of Red Ginseng Ethanol Extract | |
| CN111973486A (en) | Ceramide moisturizing and moisture-keeping cream and preparation method thereof | |
| US20040191208A1 (en) | Cosmetic composition for men's skin care and hair care | |
| KR101736478B1 (en) | Method for manufacturing lotions with effective in treating acne | |
| CN111973501A (en) | Ceramide activation milk and preparation method thereof | |
| CN118384056B (en) | Chitosan sunscreen skin care composition and preparation method thereof | |
| CN107693411B (en) | Composition containing extract of sunflower sprout and semen Ciceris Arietini with antiinflammatory effect | |
| KR101870377B1 (en) | Cosmetic composition for improving moisturizing and antioxidant containing ultrasonicating extract of cucumber seed | |
| CN109771326B (en) | Composition for whitening and repairing mask | |
| CN112472629A (en) | Alpinia officinarum and amomum tsao-ko sun-proof emulsion and preparation method thereof | |
| KR101876744B1 (en) | A step 3 method for improving skin condition using cosmetic composition comprising a ginseng extract | |
| KR20210072966A (en) | Nanocapsule composition for skin moisturizing or skin inflammatory improvement comprsing encapsulated centella and calamine | |
| KR101367703B1 (en) | Composition of cosmetic and treating skin disease | |
| JP3660833B2 (en) | Blood circulation promoter | |
| JP3987733B2 (en) | Fibroblast activator and skin external preparation containing the same | |
| KR20150116504A (en) | A cosmetics composition containing tea tree and solt | |
| KR100574233B1 (en) | Cosmetic composition containing plant extracts having skin moisturizing and anti-irritant effects | |
| KR20090075281A (en) | Cosmetic composition for improving atopic dermatitis | |
| KR101436819B1 (en) | Cosmetic composition for moisturing, soothing skin and improving acne | |
| CN108186427B (en) | Antibacterial toner and preparation method thereof | |
| CN113368026A (en) | Moisturizing, anti-wrinkle, nourishing and skin-care gel and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20170110 |
|
| PA0201 | Request for examination | ||
| PA0302 | Request for accelerated examination |
Patent event date: 20170111 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20170110 Patent event code: PA03021R01I Comment text: Patent Application |
|
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20170309 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20170508 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20170510 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20170510 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20210225 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20220301 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20230227 Start annual number: 7 End annual number: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20240425 Start annual number: 8 End annual number: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20250225 Start annual number: 9 End annual number: 9 |